IL13 and airway hyperresponsiveness: In an animal model of acute allergic asthma, addition of CD200R ligand intratracheally before allergen challenge reduces airway hyperresponsiveness, IL-13 levels in bronchoalveolar lavage (BAL), and lung dendritic cell accumulation, without reducing eosinophil recruitment (22, 23).